Any entity is permitted to provide custodial services by establishing a subsidiary at GIFT-IFSC
Any entity shall be permitted to provide custodial services by establishing a subsidiary at GIFT-IFSC. The subsidiary established shall be subject to prior approval by the Authority.
Fertilizer (Inorganic, Organic or Mixed) (Control) second Amendment Order, 2021
Every person, desirous of obtaining approval of any nano fertiliser shall make an application in Form-G-4 in duplicate to the Controller along with a report of the State Agriculture University or of the Indian Council of Agricultural Research on multi-locational and multi crop bio-efficacy trial of minimum one season and also a report from any of the NABL accredited laboratories on biosafety, biotoxicity and quality trial as per the guidelines issued by the Department of Bio-Technology.
Punjab Water Regulation and Development Authority (Conduct of Business) Regulations, 2021
The Authority may initiate any proceeding suo moto or on a petition filed by a petitioner, applicant or an affected person. The Authority may, if it considers it to be appropriate, issue orders for issue of public notice inviting comments from affected persons on the issues involved in the proceedings in such form as the Authority may direct.
IRDAI issues guidelines on Standard Personal Accident Insurance Product.
Every General and Standalone Health Insurer, who has been issued a Certificate of Registration to transact General and/or Health Insurance Business, shall mandatorily offer standard Individual Personal Accident product.
The Central Motor Vehicles Draft Amendment Rules, 2021.
The electronic enforcement device used for issuance of a challan shall have an approval certificate signed by an appropriate police officer or designated authority certifying that the device is accurate and operating properly.
The Safety Glass (Quality Control) Amendment Order, 2021.
The Ministry of Commerce and Industry on 25th February 2021 has published The Safety Glass (Quality Control) Amendment Order, 2021 to further amend the Safety Glass (Quality Control) Order, 2020 in which it has clarified that this order shall be in force with effect from 1st April 2022.
The Report of all Serious Adverse Events shall be filed through SUGAM portal from 14th March 2021.
As per “The New Drugs and Clinical Trials Rules, 2019”, Investigator, Sponsor/CT-NOC Holder and Ethics Committee shall report all Serious Adverse Events (SAE’s)to the Central Licensing Authority within a prescribed time bound manner as specified in Rule 42 of the said rules.
